2.2. Propagation of VZVeGFP-ORF23 in ARPE19 cells

JG Jonas Govaerts
EB Elise Van Breedam
SB Sarah De Beuckeleer
CG Charlotte Goethals
CD Claudio Peter D’Incal
JS Julia Di Stefano
SC Siebe Van Calster
TB Tamariche Buyle-Huybrecht
MB Marlies Boeren
HR Hans De Reu
SP Søren R Paludan
MT Marc Thiry
ML Marielle Lebrun
CS Catherine Sadzot-Delvaux
HM Helena Motaln
BR Boris Rogelj
JW Johan Van Weyenbergh
WV Winnok H De Vos
WB Wim Vanden Berghe
BO Benson Ogunjimi
PD Peter Delputte
PP Peter Ponsaerts
request Request a Protocol
ask Ask a question
Favorite

The human retinal pigment epithelial cell line ARPE19 (ATCC, CRL-2302) was used for the propagation of the VZVeGFP-ORF23 strain, as previously described (25, 28). In this pOka-derived recombinant VZV strain, the minor capsid protein ORF23 is fused with the enhanced green fluorescent protein (eGFP). Following VZVeGFP-ORF23 propagation in ARPE19 cells, infected cells were harvested and cryopreserved in 900µL cARPE19 medium [90% DMEM/F12 (Gibco, 11320-074) + 10% FBS (Gibco, 10270-106)] + 100µL DMSO (Sigma, D2650) at a concentration of 1.0 x 106 cells per vial. After thawing, VZVeGFP-ORF23 titres in plaque-forming units (PFU) were determined using an infectious foci assay in ARPE19 cells, according to previously described procedures (25, 28, 29).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A